Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Flavonoid-Rich Orange Juice Intake and Altered Gut Microbiome in Young Adults with Depressive Symptom: A Randomized Controlled Study. β
Nutrients (Nutrients ) Vol: 12 Issue 6 Pages: Pub: 2020 Jun 18 Epub: 2020 Jun 18 Authors Park M , Choi J , Lee HJ , |
|
|
Blood orange juice intake changes specific bacteria of gut microbiota associated with cardiometabolic biomarkers. β
Go to Publication β
Frontiers in microbiology (Front Microbiol ) Vol: 14 Issue Pages: 1199383 Pub: 2023 Epub: 2023 Jul 4 Authors Corrêa TAF , Tobaruela EC , Capetini VC , Quintanilha BJ , Cortez RV , Taddei CR , Hassimotto NMA , Hoffmann C , Rogero MM , Lajolo FM , |
|
|
Effects of orange juice formulation on prebiotic functionality using an in vitro colonic model system. β
Go to Publication β
PloS one (PLoS One ) Vol: 10 Issue 3 Pages: e0121955 Pub: 2015 Epub: 2015 Mar 25 Authors Costabile A , Walton GE , Tzortzis G , Vulevic J , Charalampopoulos D , Gibson GR , |
|
|
Integrated multi-omics analysis reveals the positive leverage of citrus flavonoids on hindgut microbiota and host homeostasis by modulating sphingolipid metabolism in mid-lactation dairy cows consuming a high-starch diet. β
Go to Publication β
Microbiome (Microbiome ) Vol: 11 Issue 1 Pages: 236 Pub: 2023 Oct 25 Epub: 2023 Oct 25 Authors Zhao Y , Yu S , Zhao H , Li L , Li Y , Liu M , Jiang L , |
|
|
Multi-omics analysis of a prebiotic intervention with pectin in lipid transfer proteins (LTPs) allergic patients. β
Go to Publication β
Carbohydrate polymers (Carbohydr Polym ) Vol: 369 Issue Pages: 124236 Pub: 2025 Dec 1 Epub: 2025 Aug 14 Authors Gómez F , Pérez-Sánchez N , Macías-Camero A , Núñez R , Contreras N , Cañas JA , Jiménez-Sánchez IM , Díez-Echave P , Barbas C , Guéant JL , Barber D , Vieths S , Scheurer S , Villaseñor A , Rodríguez-Nogales A , Mayorga C , Torres MJ , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
